Market Access/ News/ News/ R&D Lilly axes trial of Hanmi’s arthritis drug Richard Staines Eli Lilly, Hanmi, R&D, Rheumatoid arthritis 0 Comment Lilly may decide to develop drug in other indications Share X Lilly axes trial of Hanmi’s arthritis drug https://pharmaphorum.com/news/lilly-axes-trial-hanmis-hm71224-ra/
Digital/ Healthcare/ News/ News/ Oncology South Korea hopes big data will boost life sciences industry Richard Staines big data, digital health, Eli Lilly, Genomics England, Hanmi 0 Comment South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry. Share X South Korea hopes big data will boost life sciences industry https://pharmaphorum.com/digital/south-korea-hopes-big-data-will-boost-life-sciences-industry/
News/ R&D Genentech and Hanmi strike $900m cancer deal Richard Staines cancer, Hanmi, partnership, R&D, Roche 0 Comment Roche unit partners with South Korean firm. Share X Genentech and Hanmi strike $900m cancer deal https://pharmaphorum.com/news/genentech-and-hanmi-strike-900m-cancer-deal/
Articles/ Digital and Social Media/ Views and analysis Digital Health Round-up – NHS & DeepMind, funding for Aprecia & more Marco Ricci Aprecia, clinical trials, digital health, Google DeepMind, Hanmi, medtech, NHS 0 Comment A round-up of this week’s top digital healthcare news. Marco Ricci reports. Share X Digital Health Round-up – NHS & DeepMind, funding for Aprecia & more https://pharmaphorum.com/views-and-analysis/digital-health-round-nhs-recruits-deepmind-aprecia-gets-funding/